Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1993-7-13
|
pubmed:abstractText |
We previously presented an experimental model of Barrett's adenocarcinoma of the esophagus by demonstrating that esophagojejunostomy combined with subcutaneous injection of 2,6-dimethylnitrosomorpholine in Sprague-Dawley rats resulted in development of adenocarcinoma in the distal esophagus. The present study was devised to investigate the influence of pancreatic and biliary duodenal-content reflux on the induction of esophageal carcinoma. Three groups of 8-week-old Sprague-Dawley rats were controls: the first was exposed to pancreatic reflux, the second to biliary reflux, and the third to both. The other three experimental groups were similar except that a 1/100 LD50 dose of 2,6-dimethylnitrosomorpholine was injected subcutaneously weekly, starting on day 15. Carcinoma of the esophagus was induced only in animals receiving the carcinogen after exposure to either pancreatic reflux (3/22, 13%) or pancreatic and biliary reflux (9/27, 33%). Half of the carcinomas were adenocarcinoma and half were squamous cell carcinoma. These findings suggest that under these experimental conditions, in which the carcinogen is used in a low dose, esophageal carcinoma is induced only when pancreatic secretions are present in the duodenal-content reflux. Biliary reflux, however, appears to exert a cocarcinogenic effect when combined with pancreatic secretions. The clinical relevance of these findings needs further evaluation. Conceivably, the elimination of pancreatic and biliary duodenal-content reflux in patients with documented Barrett's mucosa may inhibit the progression from metaplasia to adenocarcinoma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0003-4975
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1386-92; discussion 1392-3
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8512386-Adenocarcinoma,
pubmed-meshheading:8512386-Animals,
pubmed-meshheading:8512386-Barrett Esophagus,
pubmed-meshheading:8512386-Bile Reflux,
pubmed-meshheading:8512386-Carcinoma, Squamous Cell,
pubmed-meshheading:8512386-Duodenogastric Reflux,
pubmed-meshheading:8512386-Esophageal Neoplasms,
pubmed-meshheading:8512386-Esophagitis, Peptic,
pubmed-meshheading:8512386-Esophagus,
pubmed-meshheading:8512386-Female,
pubmed-meshheading:8512386-Male,
pubmed-meshheading:8512386-Nitrosamines,
pubmed-meshheading:8512386-Pancreatic Juice,
pubmed-meshheading:8512386-Rats,
pubmed-meshheading:8512386-Rats, Sprague-Dawley
|
pubmed:year |
1993
|
pubmed:articleTitle |
Influence of pancreatic and biliary reflux on the development of esophageal carcinoma.
|
pubmed:affiliation |
Section of General Thoracic Surgery, Mayo Clinic, Rochester, Minnesota 55905.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|